Sapan Desai
Sapan Desai is an American physician and researcher known for his work in the field of vascular surgery and for founding the Surgisphere Corporation. He gained significant attention in 2020 due to controversies surrounding data provided by Surgisphere for studies on COVID-19 treatments.
Early Life and Education[edit | edit source]
Sapan Desai was born in the United States. He pursued his undergraduate studies in biomedical engineering at Northwestern University. Desai then attended medical school at the University of Illinois College of Medicine, where he earned his MD. He also holds a PhD in biomedical informatics and a MBA.
Career[edit | edit source]
Desai completed his residency in vascular surgery and subsequently worked as a surgeon. He has been involved in various research projects and has published numerous articles in medical journals. Desai is particularly interested in the application of artificial intelligence and big data in healthcare.
Surgisphere Corporation[edit | edit source]
In 2008, Desai founded the Surgisphere Corporation, a healthcare analytics company. The company claimed to have developed a large, international database of healthcare records, which it used to provide data for research studies.
Controversies[edit | edit source]
In 2020, Surgisphere was involved in a major controversy when data it provided was used in studies published in prominent medical journals, including The Lancet and The New England Journal of Medicine. These studies examined the effects of hydroxychloroquine and other drugs on COVID-19 patients. Questions about the validity and provenance of the data led to the retraction of these studies, and Surgisphere's data practices came under intense scrutiny.
Impact and Legacy[edit | edit source]
The Surgisphere controversy had significant implications for the scientific community, highlighting the importance of data transparency and the need for rigorous peer review processes. It also raised awareness about the challenges of using big data in medical research.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
